Mice Deficient in SFRP1 Exhibit Increased Adiposity, Dysregulated Glucose Metabolism
dc.contributor.author | Bassa, Lotfi M. | |
dc.contributor.author | Gauger, Kelly J. | |
dc.contributor.author | Henchey, Elizabeth M. | |
dc.contributor.author | Brown, Melissa | |
dc.contributor.author | Schneider, Sallie S. | |
dc.date | 2022-08-11T08:08:14.000 | |
dc.date.accessioned | 2022-08-23T15:47:13Z | |
dc.date.available | 2022-08-23T15:47:13Z | |
dc.date.issued | 2014-05-20 | |
dc.date.submitted | 2014-10-02 | |
dc.identifier.doi | 10.13028/ft2m-yz17 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/27934 | |
dc.description | <p>Abstract of poster presented at the 2014 UMass Center for Clinical and Translational Science Research Retreat, held on May 20, 2014 at the University of Massachusetts Medical School, Worcester, Mass.</p> | |
dc.description.abstract | The molecular mechanisms involved in the development of obesity and related complications remain unclear. Wnt signaling plays an important role in preadipocyte differentiation and adipogenesis. The expression of a Wnt antagonist, secreted frizzled related protein 1 (SFRP1), is increased in response to initial weight gain, then levels are reduced under conditions of extreme obesity in both humans and animals. Here we report that loss of Sfrp1 exacerbates weight gain and glucose homeostasis in mice in response to diet induced obesity (DIO). Sfrp1-/- mice fed a high fat diet (HFD) exhibited an increase in body mass accompanied by increases in body fat percentage, visceral WAT mass, and adipocyte size. Fasting glucose levels are elevated, glucose clearance is impaired, hepatic gluconeogenesis regulators are aberrantly upregulated, and glucose transporters are repressed in Sfrp1-/- mice fed a HFD. Additionally, we observed increased steatosis in the livers of Sfrp1-/- mice. Our findings demonstrate that the expression of Sfrp1 is a critical factor required for maintaining appropriate cellular signaling in response to the onset of obesity. | |
dc.format | youtube | |
dc.language.iso | en_US | |
dc.rights | Copyright the Author(s) | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/ | |
dc.subject | Biochemistry | |
dc.subject | Cellular and Molecular Physiology | |
dc.subject | Translational Medical Research | |
dc.title | Mice Deficient in SFRP1 Exhibit Increased Adiposity, Dysregulated Glucose Metabolism | |
dc.type | Poster Abstract | |
dc.identifier.legacyfulltext | https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1242&context=cts_retreat&unstamped=1 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/cts_retreat/2014/posters/22 | |
dc.identifier.contextkey | 6197578 | |
refterms.dateFOA | 2022-08-23T15:47:14Z | |
html.description.abstract | <p>The molecular mechanisms involved in the development of obesity and related complications remain unclear. Wnt signaling plays an important role in preadipocyte differentiation and adipogenesis. The expression of a Wnt antagonist, secreted frizzled related protein 1 (SFRP1), is increased in response to initial weight gain, then levels are reduced under conditions of extreme obesity in both humans and animals. Here we report that loss of Sfrp1 exacerbates weight gain and glucose homeostasis in mice in response to diet induced obesity (DIO). Sfrp1-/- mice fed a high fat diet (HFD) exhibited an increase in body mass accompanied by increases in body fat percentage, visceral WAT mass, and adipocyte size. Fasting glucose levels are elevated, glucose clearance is impaired, hepatic gluconeogenesis regulators are aberrantly upregulated, and glucose transporters are repressed in Sfrp1-/- mice fed a HFD. Additionally, we observed increased steatosis in the livers of Sfrp1-/- mice. Our findings demonstrate that the expression of Sfrp1 is a critical factor required for maintaining appropriate cellular signaling in response to the onset of obesity.</p> | |
dc.identifier.submissionpath | cts_retreat/2014/posters/22 |